1 / 2

Oral Contraceptive Market Expected To Register a CAGR of 7.2% Over 2016-2020

Along the emerging countries in Asia Pacific and increasing population global over next years, the global Oral Contraceptive market is expected to register a CAGR of 7.2% over 2016-2020.

freelykissing
Download Presentation

Oral Contraceptive Market Expected To Register a CAGR of 7.2% Over 2016-2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oral Oral Contraceptive Contraceptive Market Market Expected Expected To To Register Register a a CAGR CAGR of of 7.2% 7.2% Over Over 2016-2020 2016-2020 Date: 2016-09-02 Thanks to Oral Contraceptive’s high effectiveness (99.9% when accurately used and 92% when typically used) and convenience in use (in comparison to contraceptive devices, especially implants); drive the oral contraceptive pills segment. Along the emerging countries in Asia Pacific and increasing population global over next years, the global Oral Contraceptive market is expected to register a CAGR of 7.2% over 2016-2020. Oral contraceptive pills are the most common form of reversible contraception in the developed economies of the world such as the U.S., Canada, the Western Europe and Australia. The combined oral contraceptive pill (COCP), often referred to as the birth control pill or colloquially as “the pill”, is a birth control method that includes a combination of an estrogen (estradiol) and a progestogen (progestin). When taken by mouth every day, these pills inhibit female fertility. Combined oral contraceptive pills are available in five different packs: the 21-day pack, the 24-day pack, the 28-day pack, the 91-day pack and the four-phase regimen. Bayer’s Yaz and Loestrin are the most widely preferred brands of the 24-day pack. Barr Laboratories’ Seasonale and Teva Pharmaceutical Industries’ Seasonique are preferred in the 91-day pack sub-segment. In the four-phase regimen, Bayer’s Natazia dominates the market. Based on the product types, the global oral contraceptives market is segmented into combination pills, progestin only pills and others. Combination pills are further categorized into three segments including monophasic pills, triphasic pills and others. Oral Contraceptive market share by type as following:

  2. Read Full Report: http://www.gosreports.com/global-oral-contraceptive-pill-industry-2016-market-r esearch-report/ Joanna | Executive – International Business and partner Relations E-mail: info@gosreports.com | Tel: 1-510-400-8520 Web: www.gosreports.com

More Related